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Nonvaccine interventions have proven unreliable in the control of adenovirusassociated acute respiratory disease (1) . Before live, oral, enteric-coated adenovirus types 4 and 7 vaccines were introduced in 1971, adenovirusassociated acute respiratory disease produced high attack rates and excessive illness in soldiers during service-entry basic combat training (2) . The subsequent policy to vaccinate all male trainees during basic combat training drastically reduced adenovirus type 4-and type 7-associated acute respiratory disease (3) .
In 1996, the sole manufacturer of the vaccines ceased production (4) . To conserve the remaining vaccine lots, the army restricted use of adenovirus vaccines to the period of September 1 through March 31, the peak season for acute respiratory disease. Administration of adenovirus vaccines to military trainees was suspended on March 31, 1997, at all army basic training centers. To monitor the impact of this modified policy, intensive, laboratory-based surveillance was initiated in late April 1997 at Fort Jackson, South Carolina, the army's largest basic combat training center. An epidemic of adenovirus type 4-associated acute respiratory disease occurred among male and female soldiers in basic combat training at Fort Jackson after the vaccination was suspended. The first case appeared in late May, and the outbreak lasted until December, after vaccination was resumed in November.
The Outbreak
During May through December 1997, a monthly average of 6,847 soldiers from all geographic regions of the United States and its protectorates were engaged in the 8-week basic combat training program at Fort Jackson. During this period, 38.2% of the trainees were women. The mean age of soldiers enrolled in this study was 19.7 years.
All trainees who report to sick call with fever of 100.5° F or higher are admitted to a minimalcare hospital ward at the Fort Jackson Army Hospital for observation and self-care. Soldiers from this group who had an oral temperature of 100.5° F or higher, plus at least one sign or symptom of an upper respiratory infection, were enrolled in the surveillance program. Approximately 80% of soldiers hospitalized with acute respiratory disease were enrolled since patients admitted on weekends were not included. A pharyngeal swab was taken from each trainee (5) . Each culture was also tested for influenza A and B; parainfluenza 1, 2, and 3; herpes simplex virus; and enteroviruses by cell culture, enzyme immunoassay, and fluorescent antibody staining.
The first isolate of adenovirus type 4 came from a patient who was hospitalized on May 22, 1997, approximately 7 weeks after administration of the adenovirus vaccines ended. During May through December 1997, 1,018 basic trainees whose illness met the case definition were examined. Of these, 673 (66.1%) were positive for adenovirus type 4. No other respiratory disease agent was identified as an important cause of illness in this epidemic. The monthly case distribution was calculated by sex for all hospitalized acute respiratory disease patients ( Figure 1 ) and for adenovirus type 4-positive patients (Figure 2 ). Of the total acute respiratory disease cases, 35.3% (only slightly less than their representation in the total trainee population of 38.2%) were in women. Similarly, 31.2% of all adenovirus type 4 isolates were from women. During May, June, and July, the monthly rates of acute respiratory disease admissions were higher for women than for men (Figure 1 ). These higher rates were not due to adenovirus type 4 ( Figure 2 ) or any other agent tested for in this study.
The percentage of cases from which adenovirus type 4 was isolated increased as the epidemic progressed. At its peak, almost all patients had an adenovirus type 4 isolate (Figure 3) . Isolation rates of more than 90% were seen in both male and female patients toward the end of the outbreak. At the peak of this epidemic, 
Conclusions
Traditionally, adenovirus vaccines were administered to male trainees entering basic combat training between October and April, but outbreaks due to types 4 and 7 occurred in the absence of vaccines. The year-round use of the two vaccines beginning in 1984 resulted in the elimination of outbreaks due to both the type 4 and type 7 viruses (3).
In 1994, administration of the vaccines was temporarily interrupted, and a limited outbreak occurred among male and female basic trainees at Fort Jackson (6). This outbreak, which began in 1995 approximately 5 to 6 weeks after the administration of the adenovirus vaccines was reinstated, was centered in one military unit that had not received the vaccines; the outbreak lasted only a few weeks, probably because the pool of susceptible soldiers was small. Concern about the threat of adenoviruses was validated by serologic data, which revealed that the adenoviral susceptibility of personnel entering the military in the 1990s was similar to that of personnel who entered in the 1970s (4).
The temporal relationship of this epidemic to suspension of adenovirus vaccination in March 1997 demonstrates the effectiveness of typespecific vaccine in controlling and preventing military epidemics. Trainees began and ended the 8-week basic combat training program each week, so it would take approximately 2 months for all trainees who received the vaccines to complete basic combat training and leave Fort Jackson. The first case of adenovirus type 4-associated acute respiratory disease occurred in May, approximately 7 weeks after vaccination was suspended. The epidemic continued until December 1997, when it was interrupted by the administration of adenovirus types 4 and 7 vaccines to all new soldiers and to all soldiers (men and women) already enrolled in basic combat training at Fort Jackson. The army hospital managed the acute respiratory disease patient workload during the 1997 epidemic, but the unexpected inpatient census proved stressful for staff and facilities.
When men and women had separate basic combat training programs, adenovirus-associated acute respiratory disease outbreaks were never documented in women, and the adenovirus vaccines were not administered to women (2, 4) . When the gender-integrated program started at Fort Jackson approximately 5 years ago, the decision was made to continue providing the vaccine only to men. In the limited adenovirus type 4-associated acute respiratory disease outbreak at Fort Jackson in 1995, women were hospitalized and had adenovirus type 4 isolated (6). During this large 1997 epidemic, women and men in the integrated basic combat training program were similarly affected by adenovirus type 4-associated acute respiratory disease. Early in this outbreak, admission rates for acute respiratory disease were higher in women. However, an etiologic agent was not identified. Acute respiratory disease in women in integrated basic combat training programs cannot be assumed to be the same as that observed in men and must be studied further.
Historically, adenovirus types 4 and 7 have been the major causes of acute respiratory disease in the military (2). We cannot state why type 4 caused this outbreak rather than type 7. However, documented military outbreaks demonstrate that both vaccines are necessary, since prevention of type 4-associated acute respiratory disease alone will result in the emergence of type 7-associated disease (2) .
This epidemic demonstrates that adenovirus type 4 is a major threat to both male and female soldiers in basic combat training. Additionally, it confirms that large outbreaks due to adenoviruses
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should be expected in unvaccinated basic combat trainees.
